Consolidated Statement Of Profit Or Loss

ONO PHARMACEUTICAL CO., LTD. - Filing #7602299

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
361,361,000,000 JPY
309,284,000,000 JPY
Cost of sales
93,511,000,000 JPY
85,573,000,000 JPY
Gross profit
267,850,000,000 JPY
223,711,000,000 JPY
Selling, general and administrative expenses
77,057,000,000 JPY
69,230,000,000 JPY
Other income
980,000,000 JPY
8,165,000,000 JPY
Other expenses
12,698,000,000 JPY
1,932,000,000 JPY
Operating profit (loss)
103,195,000,000 JPY
98,330,000,000 JPY
Finance income
2,710,000,000 JPY
2,693,000,000 JPY
Finance costs
874,000,000 JPY
137,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-6,000,000 JPY
4,000,000 JPY
Profit (loss) before tax
105,025,000,000 JPY
100,890,000,000 JPY
Income tax expense
24,340,000,000 JPY
25,392,000,000 JPY
Profit (loss)
80,519,000,000 JPY
80,519,000,000 JPY
80,684,000,000 JPY
166,000,000 JPY
75,425,000,000 JPY
75,497,000,000 JPY
75,425,000,000 JPY
72,000,000 JPY
Profit (loss) attributable to
Owners of parent
80,519,000,000 JPY
75,425,000,000 JPY
Non-controlling interests
166,000,000 JPY
72,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
162.19
151.11
Diluted earnings (loss) per share
162.16
151.09

Talk to a Data Expert

Have a question? We'll get back to you promptly.